Balchem Corporation
NASDAQ:BCPC · NASDAQ Global Select
+$1.03 today
Vol 0.49M · Avg 0.21M
Management
Put operating results in leadership context
Review returns on capital, executive background, insider transactions, and growth quality to judge whether management is compounding value well.
Return Metrics
ROE, ROIC & ROA over time
ROE
12.3%
avg 11.5%
ROIC
11.1%
avg 8.9%
ROA
9.1%
avg 7.5%
Analysis
ROE is currently the strongest return metric at 12.3% versus its period average of 11.5%. 2 of 3 return metrics are above their quality threshold, which helps indicate how efficiently the company turns capital and assets into profit.
Management
Key executives, compensation & ownership
| Name | Title | Compensation | Tenure | Age | Shares Owned | Ownership % |
|---|---|---|---|---|---|---|
Theodore L. Harris | Chief Executive Officer, President & Chairman | $3.69M | — | 61 | $91,373.00 | 0.28% |
Carl Martin Bengtsson | Executive Vice President, Chief Financial Officer, Treasurer & GM of Animal Nutrition and Health | $1.47M | — | 49 | $27,926.00 | 0.09% |
Frederic Boned | Senior VP, Head of Digital Transformation & AI and GM of Human Nutrition & Health | $1.25M | — | 47 | $8,978.00 | 0.03% |
Hatsuki Miyata | Executive Vice President, Chief Legal Officer & Secretary | $1.22M | — | 50 | $8,745.00 | 0.03% |
Brent Tignor | Senior Vice President & Chief Human Resources Officer | $960,140.00 | — | 48 | $10,723.00 | 0.03% |
Martin Luther Reid | Senior Vice President & Chief Supply Chain Officer | $890,244.00 | — | 59 | $27,926.00 | 0.09% |
Erin L. Gilson | Vice President & Chief Accounting Officer | $560,792.00 | — | — | $46.00 | <0.01% |
Job L. van Gunsteren | Senior Vice President & GM of Specialty Products | — | — | 49 | $10,149.00 | 0.03% |
George Graham | Senior Vice President and Chief R&D Officer | — | — | 56 | $3,200.00 | <0.01% |
Insider Trading
SEC Form 4 transactions — last 12 months
Buys
0
$0.00
Sells
5
$2.34M
Net Sentiment
$2.34M
Net selling
Most Active
van Gunsteren Job Leonard
2 transactions
Analysis
Insiders reported 0 buys worth $0.00 and 5 sells worth $2.34M over the last 12 months. That adds up to net selling of $2.34M. van Gunsteren Job Leonard was the most active insider with 2 transactions.
Growth Analysis
Historical CAGR & forward analyst estimates
| Metric | 10yr | 5yr | 3yr | Fwd Est. |
|---|---|---|---|---|
| EPS | N/A | N/A | +12.7% | N/A0 analysts |
| Revenue | N/A | N/A | +21.2% | +6.3% (14yr)1 analysts |
| Net Income | N/A | N/A | +14.3% | N/A1 analysts |
| EBIT | N/A | N/A | +16.3% | +9.6% (14yr)1 analysts |
Analysis
Recent growth has been strongest in Revenue at +21.2% over three years. Forward estimates point to EBIT at +9.6% (14yr), giving you a quick check on whether expectations are accelerating or cooling.
Competitors
Peer companies in the same sector
Element Solutions Inc
NYSE:ESI
$11.30B
Axalta Coating Systems Ltd.
NYSE:AXTA
$7.31B
Eldorado Gold Corporation
NYSE:EGO
$6.91B
Sasol Limited
NYSE:SSL
$6.82B
SSR Mining Inc.
NASDAQ:SSRM
$6.65B
Perimeter Solutions, Inc.
NYSE:PRM
$5.87B
Sensient Technologies Corporation
NYSE:SXT
$4.71B
Cabot Corporation
NYSE:CBT
$4.62B
H.B. Fuller Company
NYSE:FUL
$3.51B
Hawkins, Inc.
NASDAQ:HWKN
$3.33B
Who manages BCPC?
Balchem Corporation (BCPC) lists 9 active executives. The top listed executive is Frederic Boned, Senior VP, Head of Digital Transformation & AI and GM of Human Nutrition & Health.
Are BCPC insiders buying or selling?
Recent insider activity shows net selling of $6.09M.
Explore More
Continue the stock analysis
Jump to another research area for this company.